• OPEN AN ACCOUNT
Indian Indices
Sensex
77,157.74 200.47
( 0.26%)
Global Indices
Nasdaq
53,227.35 -353.64
(-0.66%)
Dow Jones
7,711.10 -21.66
(-0.28%)
Hang Seng
66,147.06 -258.50
(-0.39%)
Nikkei 225
10,824.26 31.76
(0.29%)
Forex
USD-INR
95.47 -0.01
(-0.01%)
EUR-INR
110.57 -0.67
(-0.60%)
GBP-INR
129.19 -0.55
(-0.42%)
JPY-INR
0.60 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Venus Remedies Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
526953
INE411B01019
515.9180123
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VENUSREM
19.64
2221.86
EPS(TTM)
Face Value()
Div & Yield %
84.64
10
0.6
 

ncc ltd
Indiamart Intermesh consolidated net profit declines 72.20% in the March 2026 quarter
Apr 30,2026
Net profit of Indiamart Intermesh declined 72.20% to Rs 50.20 crore in the quarter ended March 2026 as against Rs 180.60 crore during the previous quarter ended March 2025. Sales rose 13.86% to Rs 404.30 crore in the quarter ended March 2026 as against Rs 355.10 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.80% to Rs 474.70 crore in the year ended March 2026 as against Rs 550.70 crore during the previous year ended March 2025. Sales rose 13.01% to Rs 1569.00 crore in the year ended March 2026 as against Rs 1388.40 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales404.30355.10 14 1569.001388.40 13
OPM %29.6633.60 -30.2934.12 -
PBDT85.40226.40 -62 676.30738.70 -8
PBT78.40218.10 -64 647.90705.80 -8
NP50.20180.60 -72 474.70550.70 -14